Concord Drugs Ltd - 538965 - Board Meeting Intimation for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31.12.2023.
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Un-Audited financial results (Standalone and Consolidated) for the quarter ended 31.12.2023. Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under reg. 74(5) Concord Drugs Ltd - 538965 - Clarification sought from Concord Drugs Ltd
The Exchange has sought clarification from Concord Drugs Ltd on December 29, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication Concord Drugs Ltd - 538965 - Statement Of Deviation For The Quarter Ended 30.09.2023
Statement of Deviation for the quarter ended 30.09.2023 Concord Drugs Ltd - 538965 - Un-Audited Financial Results (Both Standalone And Consolidated) For The Quarter Ended 30.09.2023
Un-Audited Financial Results (Both Standalone and Consolidated) for the quarter ended 30.09.2023 Concord Drugs Ltd - 538965 - Board Meeting Intimation for To Consider And Approve Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2023.
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve Un-Audited financial results (Standalone and Consolidated) for the quarter and half year ended 30.09.2023. Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy & PACs